Clinicians should be aware of the potential for persistent TIPN and its impact on patients' function and QOL. Future research should focus on large prospective studies with systematic TIPN assessments during and after treatment to better understand which symptoms and patient characteristics predict resolution. This information can guide treatment decisions, balancing the need for effective chemotherapy with minimizing long-term impairments in function and QOL.
Keyphrases
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- risk factors
- prognostic factors
- squamous cell carcinoma
- diabetic rats
- risk assessment
- locally advanced
- current status
- drug induced
- patient reported outcomes
- physical activity
- health information
- sleep quality
- human health
- social media
- climate change